Longbow Capital has rolled out a new tax-efficient fund, Private Equity Wire reports. The Longbow Growth and Income VCT will enable investors to invest in the U.K.’s healthcare technology sector.

The vehicle is expected to invest in products developed at the Boots Centre for Innovation. The fund may invest in AmbulightPDT LED light product from Ambicare, which treats non melanoma skin cancer.

Click here for the story from Private Equity Wire.